AVADEL PHARMACEUTICALS (AVDL) Stock Analyst Earnings Estimates
NASDAQ:AVDL - Nasdaq - IE00BDGMC594 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 27.963M | 169.117M 504.79% | 254.99M 50.78% | 337.71M 32.44% | 407.75M 20.74% | 470.19M 15.31% | 546.88M 16.31% | 428.4M -21.66% | ||
| EBITDA YoY % growth | -93.723M -10.54% | -136.083M -45.20% | -39.718M 70.81% | 82.278M 307.16% | 187.13M 127.44% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -95.216M -11.23% | -137.849M -44.78% | -42.399M 69.24% | 26.984M 163.64% | 118.33M 338.52% | 204.1M 72.48% | 223.72M 9.61% | 254.9M 13.94% | 198.9M -21.97% | |
| Operating Margin | N/A | -492.97% | -25.07% | 10.58% | 35.04% | 50.06% | 47.58% | 46.61% | 46.43% | |
| EPS YoY % growth | -2.25 -70.45% | -2.01 10.67% | -0.52 74.13% | 0.08 115.52% | 0.70 761.15% | 2.44 251.47% | 2.81 15.03% | 2.44 -13.25% | N/A |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.05 82.19% | 0.00 98.73% | 0.04 240.69% | 0.09 273.91% | 0.03 157.27% | 0.11 6,385.71% | 0.14 238.33% | 0.22 158.06% |
| Revenue Q2Q % growth | 54.469M 100.42% | 61.528M 48.25% | 67.666M 35.26% | 72.526M 43.87% | 67.422M 23.78% | 78.03M 26.82% | 82.722M 22.25% | 93.636M 29.11% |
| EBITDA Q2Q % growth | 4.583M 117.98% | 10.608M 190.18% | 17.836M 957.89% | 25.622M 4,259.42% | 7.242M 58.02% | 17.136M 61.54% | 21.522M 20.67% | 31.62M 23.41% |
| EBIT Q2Q % growth | -1.651M 93.66% | 4.312M 133.84% | 9.887M 3,123.55% | 15.897M 582.17% | 5.61M 439.77% | 15.402M 257.19% | 19.788M 100.14% | 29.988M 88.64% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.05 82.76% | -0.04 | -0.01 | -20.15% |
| Q3 2024 Q2Q % growth | -0.03 92.68% | -0.06 | 0.03 | 46.72% |
| Q2 2024 Q2Q % growth | -0.14 83.13% | -0.16 | 0.02 | 11.79% |
| Q1 2024 Q2Q % growth | -0.30 37.50% | -0.21 | -0.09 | -41.55% |
| Q4 2023 Q2Q % growth | -0.29 36.96% | -0.26 | -0.03 | -9.63% |
| Q3 2023 Q2Q % growth | -0.41 -24.24% | -0.38 | -0.03 | -7.98% |
| Q2 2023 Q2Q % growth | -0.83 17.82% | -0.39 | -0.44 | -111.75% |
| Q1 2023 Q2Q % growth | -0.48 -6.67% | -0.38 | -0.10 | -24.86% |
| Q4 2022 Q2Q % growth | -0.46 -21.05% | -0.28 | -0.18 | -66.41% |
| Q3 2022 Q2Q % growth | -0.33 13.16% | -0.26 | -0.07 | -27.71% |
| Q2 2022 Q2Q % growth | -1.01 -206.06% | -0.42 | -0.59 | -141.71% |
| Q1 2022 Q2Q % growth | -0.45 -95.65% | -0.44 | -0.01 | -2.01% |
| Q4 2021 Q2Q % growth | -0.38 -100.00% | -0.42 | 0.04 | 10.01% |
| Q3 2021 Q2Q % growth | -0.38 -90.00% | -0.39 | 0.01 | 3.23% |
| Q2 2021 Q2Q % growth | -0.33 -120.00% | -0.32 | -0.01 | -2.89% |
| Q1 2021 Q2Q % growth | -0.23 -1,050.00% | -0.32 | 0.09 | 29.04% |
| Q4 2020 Q2Q % growth | -0.19 -171.43% | -0.28 | 0.09 | 31.29% |
| Q3 2020 Q2Q % growth | -0.20 16.67% | -0.26 | 0.06 | 21.96% |
| Q2 2020 Q2Q % growth | -0.15 34.78% | -0.10 | -0.05 | -52.79% |
| Q1 2020 Q2Q % growth | -0.02 94.29% | -0.24 | 0.22 | 91.76% |
| Q4 2019 Q2Q % growth | -0.07 | -0.25 | 0.18 | 71.99% |
| Q3 2019 Q2Q % growth | -0.24 | -0.28 | 0.04 | 12.85% |
| Q2 2019 Q2Q % growth | -0.23 | -0.30 | 0.07 | 22.24% |
| Q1 2019 Q2Q % growth | -0.35 | -0.50 | 0.15 | 29.97% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 50.41M 159.14% | 51.034M | -624K | -1.22% |
| Q3 2024 Q2Q % growth | 50.025M 613.22% | 49.579M | 446K | 0.90% |
| Q2 2024 Q2Q % growth | 41.504M 2,674.33% | 38.285M | 3.219M | 8.41% |
| Q1 2024 Q2Q % growth | 27.178M | 26.416M | 762K | 2.88% |
| Q4 2023 Q2Q % growth | 19.453M | 18.574M | 879K | 4.73% |
| Q3 2023 Q2Q % growth | 7.014M | 5.19M | 1.824M | 35.14% |
| Q2 2023 Q2Q % growth | 1.496M | 643.763K | 852.237K | 132.38% |
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | % | ||
| Q4 2020 Q2Q % growth | -100.00% | % | ||
| Q3 2020 Q2Q % growth | -100.00% | % | ||
| Q2 2020 Q2Q % growth | 10.091M -42.51% | 7.516M | 2.575M | 34.26% |
| Q1 2020 Q2Q % growth | 12.243M -25.52% | 10.353M | 1.89M | 18.26% |
| Q4 2019 Q2Q % growth | 10.995M | 9.316M | 1.679M | 18.02% |
| Q3 2019 Q2Q % growth | 14.229M | 10.455M | 3.774M | 36.10% |
| Q2 2019 Q2Q % growth | 17.554M | 10.71M | 6.844M | 63.90% |
| Q1 2019 Q2Q % growth | 16.437M | 14.153M | 2.284M | 16.14% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 8.11% | -413.53% | -6.59% | -83.5% |
| Revenue | 0.07% | -7.05% | -0.46% | -14.3% |